Journal article
PANCREOX: A randomized phase 3 study of 5FU/LV with or without oxaliplatin for second-line advanced pancreatic cancer (APC) in patients (pts) who have received gemcitabine (GEM)-based chemotherapy (CT).
Authors
Gill S; Ko Y-J; Cripps MC; Beaudoin A; Dhesy-Thind SK; Zulfiqar M; Zalewski P; Do T; Cano PO; Lam W
Journal
Journal of Clinical Oncology, Vol. 32, No. 15_suppl, pp. 4022–4022
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2014
DOI
10.1200/jco.2014.32.15_suppl.4022
ISSN
0732-183X